Bio-Techne Corporation (1TECH)
MTA
Real-time Data
07:00 AM
Day's Range
62.5052 wk Range
43.60Overview - 1TECH - Bio-Techne Corporation
Key Statistics
Valuation
Enterprise Value
8.50B
P/E (Trailing)
‪63.89‬
PEG Ratio
‪0.47‬
Price / Sales (TTM)
‪8.11‬
Price / Book
‪5.47‬
EV / EBITDA
‪27.98‬
Profitability
Gross Margin
‪66.88%‬
Profit Margin
‪14.96%‬
Operating Margin
‪23.45%‬
Return on Assets
‪6.26%‬
Return on Equity
‪9.03%‬
Ownership
Shares Outstanding
156.51M
Float
155.44M
Held by Insiders
‪0.33%‬
Held by Institutions
‪114.94%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪61.02‬
200-Day Avg
‪56.51‬
Dividends
Payout Ratio
‪27.59%‬
Frequency
Quarterly
Market Cap - 1TECH - Bio-Techne Corporation
Peers - 1TECH - Bio-Techne Corporation
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1TECHMTABio-Techne Corporation8.56BMarket Cap+25.44%52-week change63.90P/E (Trailing)‪14.96%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+27.69%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+47.15%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1TECH - Bio-Techne Corporation
About
Bio-Techne Corporation is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics serving the research, diagnostic, and bioprocessing markets worldwide. The company operates through two primary segments: protein sciences, which develops biological…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
